← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dfh Pharma, Inc.
Gaithersburg, MD
$2,287,827
Total funding
4
Grants
Funding over time
peak $986.9K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,287,827 · 4
By mechanism
R44$986,894 · 1
R42$943,084 · 1
R41$357,849 · 2
Investigators at Dfh Pharma, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
IND-Enabling Development of HIV Maturation Inhibitors Formulated for use as either Oral or Long-Acting Parenterally Administered Agents$986,894
R44 · FY2025 · AI
Preclinical Development of 2nd Generation HIV Maturation Inhibitors$518,708
R42 · FY2020 · AI
Preclinical Development of 2nd Generation HIV Maturation Inhibitors$424,376
R42 · FY2021 · AI
Preparation and Characterization of 2nd Generation HIV-1 Maturation Inhibitor Dru$186,374
R41 · FY2013 · AI
Preclinical Development of 2nd Generation HIV Maturation Inhibitors$171,475
R41 · FY2018 · GM